1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with pentylenetetrazole in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (pentylenetetrazole) | Trials (pentylenetetrazole) | Recent Studies (post-2010) (pentylenetetrazole) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 6,737 | 30 | 1,496 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballati, L; Boni, P; Castellucci, A; Evangelista, S; Perretti, F; Toja, E; Tramontana, M | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and pentylenetetrazole
| Article | Year |
|---|---|
Pharmacodynamic profile of the new potent antibronchospastic agent 7-[(2,2-dimethyl)propyl]-1-methyl xanthine.
Topics: Acetylcholine; Animals; Blood Pressure; Bronchial Spasm; Bronchoconstriction; Bronchodilator Agents; Drug Interactions; Exudates and Transudates; Gastric Mucosa; Gastrointestinal Transit; Guinea Pigs; Heart Rate; In Vitro Techniques; Male; Mice; Motor Activity; Pentylenetetrazole; Platelet Activating Factor; Rats; Rats, Wistar; Sleep; Xanthines | 1995 |